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Abstract
Dietary elimination of causative food ingredients, usually food proteins, is the 
basis of treating food hypersensitivity. Proper diagnostic assessment is essential to 
avoid burdening children with unnecessary dietary restrictions with potential adverse 
effects. Diagnosis requires a detailed history, allergen elimination, and re-challenge 
with suspected foods. Complete elimination of causative food components depends on 
professional counseling and training of the patient and family, and transparent label-
ing of food products. Elimination diets carry the risk of inducing insufficient supplies 
of critical nutrients with adverse effects on health and wellbeing, particularly in chil-
dren with exclusion of foods that provide a major part of dietary supply and patients 
with multiple food allergies. Infants and young children with cow’s milk allergy, who 
have not been fully breastfed, require milk substitutes based on extensively hydro-
lyzed protein or amino acids. Elimination diets must be supervised and monitored to 
a similar degree as drug treatments, and the need for continued dietary elimination 
should be reviewed on a regular basis and re-challenges considered.
Copyright © 2009 Nestec Ltd., Vevey/S. Karger AG, Basel
Introduction
Food allergy has reached an estimated prevalence of 6–8% of children 
affected at some time during childhood in many countries around the world 
with a ‘Western lifestyle’. The most common causative foods are milk pro-
teins, egg, wheat, soy, peanut and tree nuts, fish and shell fish which account 
for ~90% of all food allergies in children. The relative frequency of reactions 
to various allergens differs depending on regional infant feeding patterns 
[1]. Allergic food reactions are also caused by a large variety of other food-
stuffs. Generally, all foods containing peptides or proteins may elucidate aller-




















   
   
   
   
   
   
   
   
   
   
   























minority may react to several or almost all common foods (multiallergenic). 
These children are a particular therapeutic challenge.
Manifestation and prognosis of food allergies are modulated by the caus-
ative allergen, clinical manifestation, age at diagnosis, and underlying immu-
nological mechanisms, all of which should be considered in management. 
Most children with cow’s milk protein (CMP) allergy (CMPA) or hen’s egg 
allergy become tolerant by the age of 3–5 years [2], but allergies against pea-
nuts, fish and shellfish often persist. Children with positive specific IgE anti-
bodies against causative food at diagnosis tend to develop tolerance to these 
food antigens later than those negative for specific antibodies or skin prick 
test reactions [2].
Treating food allergy and other food intolerances is based on dietary elimi-
nation of causative food ingredients, usually food proteins. When a therapeu-
tic elimination diet is introduced, the focus of the patient, the patient’s family 
and healthcare providers is on the rapid and possibly complete elimination of 
symptoms, but any therapeutic diet must also adequately nourish the patient, 
i.e. it must provide all nutrients needed for growth, normal development and 
performance, and it should avoid untoward effects as much as possible. In 
infants and young children it is a particular challenge to meet all the dietary 
requirements with a restricted diet as the nutrient needs per unit body weight 
are particularly high at a young age due to the added needs for growth.
Of particular concern are restrictive elimination diets without appropriate 
counseling, and in children those based on complementary diagnostic allergy 
testing are of unproven diagnostic value [3]. Food allergy is often miscon-
ceived. For example, the self-reported lifetime prevalence of adverse food 
reactions was 34.9% in over 4,000 German persons (mean age 41 years) [4], 
of whom 20% altered their diet because of perceived adverse reactions to 
food. Noimark and Cox [5] reported a 5-year-old boy with mild atopic eczema 
who developed failure to thrive due to exclusion of a variety of foods including 
dairy products, eggs, gluten, beef, chicken, fish, citrus, tomatoes and straw-
berries, after evaluation by a practitioner following naturopathy concepts. 
The reported hazards of elimination diets in children include rickets, kwashi-
orkor, and vitamin and mineral deficiencies. Therefore, it is essential that an 
accurate diagnosis of food allergy is made by a physician with appropriate 
training, and that allergen elimination diets are supervised by experienced 
pediatric dieticians.
Allergen Avoidance for Diagnostic Evaluation
Successful management of food allergy depends on identifying the offend-
ing foods or antigens and complete elimination. An accurate patient history 
is essential but not always sufficient to identify causative foods. Diagnostic 




















   
   
   
   
   
   
   
   
   
   
   























preferentially in a double-blind fashion, is considered the gold standard for 
diagnosing food allergy [6]. The required duration of diagnostic elimination 
diets depends on the symptoms: for acute reactions like urticaria or imme-
diate vomiting a few days are sufficient until symptoms have resolved and 
the challenge can be performed. For some gastrointestinal manifestations 
like dysmotility, allergic gastritis or enterocolitis, or for atopic dermatitis 
with more fluctuating symptoms, an elimination of 2 weeks or even longer is 
recommended.
Diagnostic elimination diets comprise: (1) elimination of one or several 
suspected food items; (2) elimination of all but a defined group of ‘allowed’ 
foods (oligoantigenic or ‘few food’ diet), and (3) formulae based on extensive 
hydrolyzed protein or amino acids.
While the first approach is preferred if causative foods are identified by a 
clear history or allergy tests, the other two options are necessary if no spe-
cific food is suspected, symptoms are unspecific and/or multiple food allergy 
is suspected. For the first two approaches and complete elimination of the 
allergens, adequate information must be provided to the parents and children 
(appropriate for their age and understanding) about the allergen, the uses of 
synonymous terms (for example, wheat and gluten or semolina, or milk and 
CMP, and whey and casein), and the types of food in which it may be found.
Oligoantigenic or ‘few food’ diets consist of one meat (turkey or lamb), one 
carbohydrate source (potato or rice) and one fruit (pear or banana), and two 
vegetables (cauliflower, broccoli, carrots, cabbage, or parsnips) plus water. 
Oligoantigenic diets should be followed no longer than 2–3 weeks [7] because 
they may result in caloric deficiency due to poor palatability, or in deficiencies 
of macro- or micronutrients due to an imbalanced diet.
Food Challenges
If symptoms resolve or improve during the elimination diet, food allergy 
should be confirmed by a controlled food challenge supervised by a physi-
cian [8]. If several foods are eliminated, these foods should be re-introduced 
one by one to identify the causative foods. In infants and very young children 
an open or single-blind challenge may be sufficient. In case of doubt and in 
children suffering from subjective symptoms like abdominal pain or nausea, 
results should be confirmed by double-blind placebo-controlled challenge, 
but false-positive and negative reactions may occur even in double-blind con-
trolled food challenges [9].
Prolonged elimination diets are only justified after diagnosis is proven by a 
positive food challenge, and not only based on positive results of specific IgE 
testing or atopy patch test. If symptoms do not improve on antigen elimina-
tion or do not exacerbate after challenge, the diet should be discontinued. In 




















   
   
   
   
   
   
   
   
   
   
   























mon, particularly cows’ milk-free diets. Sinagra et al. [10] studied 186 Italian 
children (aged 4–69 months) with atopic dermatitis for specific IgE, atopy 
patch test and oral milk protein provocation, and confirmed CMPA in only 4% 
in contrast to 24% who followed a CMP-free diet.
Allergen Avoidance for Treatment of Confirmed Food Allergy
Elimination diets remain effective and are usually the only treatment for 
food allergy, Before counseling children and caregivers one must consider 
how strict the diet must be. In case of non-IgE-mediated reactions with mild 
symptoms, e.g. constipation, mild atopic dermatitis, or reactions to only large 
doses, precautions are less important than in children with life-threatening 
reactions to very small doses. In these children oral tolerance induction has 
been attempted with some success, but complete tolerance is not achieved 
[11]. It is also unresolved whether complete and prolonged elimination may 
increase the risk of a severe acute reaction and reduces the chance of toler-
ance induction [12], or whether complete elimination leads to an earlier loss 
of allergy.
While the short duration of a diagnostic elimination diet is less likely to 
cause nutritional deficits or negative psychosocial effects, longer elimination 
diets may cause serious problems (table 1). Elimination of one food or several 
foods is easy if the food is not commonly consumed (e.g. shell fish or kiwi). 
However, elimination of foods contributing a major part to the nutrient sup-
ply (e.g. cow’s milk-based products) may put the child at significant risk, e.g. 
an inadequate calcium intake, low bone density, and rickets. Some causative 
Table 1. Risks and disadvantages of the different diagnostic or therapeutic diets, 
graded from missing (–) to strongly present (+++)
Elimination of one 
or few foods
Oligoantigenic diet Extensive hydrolyzed 
or amino acid-based 
formula
Risk of nutritional 
deficits
–/+ +++ –/+































   
   
   
   
   
   
   
   
   
   
   























antigens are hidden in products, e.g. soy or wheat proteins (table 2). For 
some antigens (e.g. peanuts, shell fish) only traces or inhalation may cause 
reactions. Food preparation may influence the severity of reactions; cooking 
reduces the antigenicity of most fruits and vegetables, but the antigenicity of 
peanuts is increased by roasting.
Risk of Malnutrition
Adverse effects of elimination diets on nutrient supply and child growth 
have been reported. Laitinen et al. [13] in Finland followed 159 children from 
birth to 4 years to evaluate a probiotic intervention. Children who developed 
atopic eczema had significantly reduced intakes of protein, vitamin A and 
calcium at different time points of the study and grew less well then chil-
dren without atopy. Children with atopic dermatitis had 5.1% lower weight 
for height (95% CI –8.9 to –1.2; p = 0.01) than controls and were significantly 
shorter at 2 years (height SD score 0.4, 95% CI 0.17–0.65) than controls (0.73, 
95% CI 0.51–0.96; p = 0.048).
Fox et al. [14] reported on a 14-month-old boy who had been exclusively 
breastfed until 5 months when complementary feeding based on rice and veg-
etables was introduced. A cow’s milk formula caused immediate generalized 
urticaria at 6 months, and a similar reaction occurred to goat’s milk-based 
formula, and atopic eczema developed. The mother continued breastfeeding 
until 14 months and provided selected complimentary foods including vege-
tables and fruits, but avoided eggs, fish and CMP. At 14 months, the child was 
severely malnourished (weight and height <3rd centile) with iron deficiency 
anemia and vitamin D deficiency rickets. Thus, dietary modification in atopic 
infants and young children may induce severe adverse effects on nutrient 
supply, growth and health, and hence appropriate and qualified guidance is 
required when using elimination diets.
Table 2. Unexpected food sources of common allergens
Food Ingredient
Soy sauce Wheat
Malt sugar, corn flakes Wheat, barley
Low-fat peanut butter Soy protein
Low-fat camembert Wheat
Sweet and sour sauce Wheat or soy
Ham Milk protein
Egg substitutes Egg white
Hamburger Soy protein




















   
   
   
   
   
   
   
   
   
   
   























Dietary exclusion of fish and seafood results in a near total elimination 
of the n-3 long-chain polyunsaturated fatty acid (PUFA), docosahexaenoic 
acid (DHA). We estimated that a 6-year-old child consuming a mixed diet 
with regular consumption of fatty fish (e.g. salmon) achieves a dietary DHA 
intake of about 640 mg/day, whereas the elimination of all fish and seafood 
would reduce the dietary DHA intake more than 30-fold to no more than 20 
mg/day [15]. This is of concern given the indications of the importance of a 
dietary DHA supply for visual and neuromotor functions in infancy and child-
hood. Children with elimination of fish and seafood from their diet should 
preferably receive an alternative source of long-chain n-3 long-chain PUFA. 
Most children with allergic reactions to seafood easily tolerate purified fish 
oils, because they are devoid of appreciable residues of fish protein, but it is 
prudent to supply the first dose under medical supervision and not to change 
the source without controlled exposure. Alternatives are DHA-rich single-cell 
oils from fermented algal sources that do not contain fish or seafood proteins. 
The supply of DHA-rich oils may be complemented by foods and oils provid-
ing the n-3 fatty acid precursor -linolenic acid, such as rapeseed oils, walnut 
oil, soybean oil, and walnuts, since over time even the limited activity of con-
version of -linolenic acid will yield some DHA.
The most frequently eliminated food allergen from the diet of infants and 
children is CMP. Compared to children on unrestricted diets, elimination of 
all foods containing CMP will usually lead to a major change in nutrient sup-
ply, with potential consequences for long-term health. Medeiros et al. [16] 
compared the food intake and nutritional status of 26 children (mean age 19 
months) on a diet free of cow’s milk and cow’s milk products  to 30 children 
(mean age 17 months) with unrestricted diets. Children on a CMP-free diet 
had lower dietary intakes of energy (p = 0.005), protein (p < 0.001), fat (p 
< 0.001), calcium (p < 0.001) and phosphorous (p < 0.001) than controls, 
and lower standard deviation scores (z scores) for height for age (–0.81 ± 
0.06 vs. +0.42 ± 0.25, p < 0.001), weight for age (–1.03 ± 1.21 vs. +0.02 ± 
0.91, p < 0.001), and weight for height (–0.63 ± 1.08 vs. +0.30 ± 1.11, p = 
0.004). Moreover, unless implementing appropriate precautions, a low intake 
of calcium and phosphorus resulting from elimination of all cow’s milk-based 
products will induce reduced bone mineralization and a decreased peak bone 
mass, with short- and long-term adverse consequences for fracture risk.
These and other observations indicate that strict dietary elimination 
without adequate precautionary measures may adversely affect substrate 
intake, child growth and long-term health and wellbeing. Therefore, elimi-
nation diets should only be introduced and maintained if one can expect a 
clear benefit. The continued need for elimination diets must be reexamined 
over time, and repeated food challenges be considered. If an elimination diet 
appears indicated and necessary, qualified dietary counseling and regular 
monitoring of growth are essential. Guided by the situation of the individual 




















   
   
   
   
   
   
   
   
   
   
   























such as plasma concentrations of vitamin D or n-3 PUFAs, or measurements 
of bone density.
Incomplete Allergen Elimination due to Contamination or 
Insufficient Labeling
Elimination diets carry the risk of incomplete elimination due to hidden anti-
gens, cross-reactivity, insufficient labeling or contamination. Contamination 
may occur at different stages of food processing or packing. This is a particu-
lar problem for grains which grow next to each other on fields, may be har-
vested and transported with the same machines and vehicles, and be ground 
in the same mill. For examples, commercial oat products very often contain 
wheat protein (gluten). Even within one and the same brand of oat products, 
a wide batch-to-batch variation in the contaminated antigens may occur from 
1,800 to <3 mg/kg [17]. Therefore, commercial oat products cannot be rec-
ommended in wheat allergy unless manufacturers certify products as wheat/
gluten-free. Another common example is the occurrence of peanut allergen in 
margarine or whole milk chocolate. The risk of allergen contamination for an 
allergic reaction or even life-threatening event depends on the threshold dose 
of an offending food eliciting adverse reactions [18] which differs between 
individuals, depends on food processing and the type of allergic reaction. 
Sicherer et al. [19] reported the dose response in double-blind, placebo-con-
trolled oral food challenges in 196 children with atopic dermatitis and known 
food allergy against egg, milk, soy, wheat, peanut or fish. About half of the 
children with milk and egg allergy reacted to a dose of 500 mg or less, some 
even to 100 mg. Neither the serum concentration of food-specific IgE nor the 
absolute wheal size on skin prick test correlated with the dose causing a reac-
tion or the severity of the reaction. Thus, even very small amounts of residual 
or contaminant allergens in food products may put a highly sensitized child 
at risk.
Correct and complete labeling of food products for frequent allergens 
is important to protect the health and wellbeing of allergic individuals. 
Legislation in the European Union requires clear labeling of any content of 20 
common food antigens on all food products, even if they occur in only small 
quantities. Patients and caregivers should be instructed to read product labels 
each time before use because ingredients may change without warning.
Cross-Reactivity of Food Antigens
Cross-reactivity of allergens due to reactions toward shared homologous 
proteins may be the cause of reactions to a variety of related foods of plant or 




















   
   
   
   
   
   
   
   
   
   
   























an Italian study; hence goat’s milk generally is not considered to be a suitable 
alternative to cow’s milk or to cow’s milk-based infant formula [20]. Milk from 
other animals like mares or camels might be safer, but these milks are not 
easily available and also are not nutritionally adequate to meet the substrate 
needs of infants. Some patients with allergy to mammalian milks also react to 
mammalian meats due to homologous proteins. Werfel et al. [21] reported beef 
allergy in 9.7% of 62 children with proven CMPA. Cross-reactivity between 
egg and avian meat occurs, particularly chicken meat allergy in patients with 
hen’s egg allergy. Children with allergic reactions to chicken meat may also 
react to other poultry such as turkey or pheasant. In fish-allergic patients 
reactions to more than one type of fish are common.
Sensitization to several allergenic plant foods (e.g. peanut, tree nuts, ses-
ame or poppy seed) is common. Reactions to peanut and tree nut (hazelnut 
and/or Brazil nut) were reported in 449 (59%) of 731 patients with peanut 
allergy [22]. Wheat, rye, barley, and to a lesser extent oat, share homologous 
proteins. Patients with wheat allergy often show co-sensitization to these dif-
ferent grains.
Breast Milk Substitutes for Infants with Cow’s Milk Protein 
Allergy
Food-allergic infants need a suitable breast milk substitute that provides 
all nutrient needs during the critical period of growth and development.
Unmodified mammalian milks, including unmodified cow’s, sheep, buffalo, 
mare or goat’s milk, and unmodified soy or rice milk, are contraindicated since 
their composition is unsuitable to meet the metabolic requirements of human 
infants, and possible allergenic cross-reactivity poses additional risks.
Infant formulae based on soy protein have widely been used in infants with 
CMPA because of the lower cost and often better taste and acceptance as 
compared to therapeutic formulae, but soy allergies are frequently observed 
in CMPA patients [23]. Allergic manifestations to soy formula in infants at risk 
of atopy is comparably higher than to cow’s milk formula [24]. Intolerance to 
soy has been reported in 10–14% [25, 26] of infants with CMPA, whether posi-
tive or negative for specific IgE antibodies to CMP [25]. The risk increased to 
25% if soy formula was introduced during the first 6 months [25]. Nutritional 
aspects of soy protein formulae have recently been reviewed by the ESPGHAN 
Committee on Nutrition [27]. Soy formulae support normal growth and nutri-
ent status [28], but soy protein is inferior to CMP in its biological value for 
infants, with a lower digestibility and bioavailability of the protein and with 
lower methionine content [27]. Accordingly, European Union legislation on 
infant formulae requires a higher minimum protein content in soy formulae 
than CMP formulae (2.25 vs. 1.8 g/100 kcal). High concentrations of alumi-




















   
   
   
   
   
   
   
   
   
   
   























long-term effects of which are unknown. ESPGHAN recommended that soy 
protein formulae should not be used in infants with food allergy during the 
first 6 months of life. If soy protein formulae is considered in food-allergic 
infants after the age of 6 months because of their lower cost and better accep-
tance relative to extensive protein hydrolysate formulae, tolerance to soy pro-
tein should first be established by clinical challenge in the individual patient 
[27]. The conclusions of ESPGHAN were largely shared by the Committee on 
Nutrition of the American Academy of Pediatrics in their recent statement 
that extensively hydrolyzed formulae, but not soy formula, should be given to 
infants with proven cow’s milk allergy [29].
The dietary treatment of choice for infants with CMPA is a therapeutic 
hypoallergenic formula based on extensively hydrolyzed protein, or on amino 
acid mixtures. Therapeutic formulae for CMPA must be tolerated by at least 
90% (with 95% confidence) of CMPA infants. To demonstrate this, a min-
imum of 29 patients with CMPA must be enrolled in a study documenting 
tolerance. If none of the 29 infants with proven CMPA reacts, then there is 
95% certainty that 90% of allergic individuals will not react to that formula 
[30]. These criteria are met by some extensively hydrolyzed formulae based 
on whey, casein or other protein sources, and by amino acid-based formulae, 
whereas formulae based on mildly hydrolyzed proteins used for allergy pre-
vention are generally unsuitable for treatment because of the residual allergen 
content [31]. Extensively hydrolyzed formulae are the first choice in infants 
with mild to moderate CMPA for reasons of cost, although in some cases the 
cost of extensively hydrolyzed formulae and amino acid-based formulae may 
be comparable [32]. However, allergic reactions even to extensively hydro-
lyzed therapeutic formulae are possible [33, 34]. Residual allergens in exten-
sively hydrolyzed formulae appear more likely to produce gastrointestinal and 
other non-IgE-associated manifestations [35, 36], but IgE-related reactions to 
extensive hydrolyzed formulae have also been reported [35]. In such infants a 
switch to another type of extensively hydrolyzed formula or to an amino acid-
based formula may be tried. Amino acid-based formulae are also indicated 
in infants or young children with a history of life-threatening (respiratory or 
anaphylactic) reactions, or in those who refuse extensively hydrolyzed formu-
lae which tend to have a more bitter taste than amino acid-based formulae.
Therapeutic hypoallergenic formulae based on extensively hydrolyzed 
proteins or on amino acid mixtures can generally be regarded as effective and 
safe, and as supporting adequate growth. However, the properties of various 
products differ, and the biological value of the nitrogen sources in extensively 
hydrolyzed proteins or amino acid mixtures for infants appears not be equal 
to that of CMP. Maggio et al. [37] compared the effects of formulae based 
on hydrolyzed CMPs and on intact CMPs in preterm infants in a randomized 
controlled trial. At equal daily feeding volumes, nitrogen and energy intakes, 
infants fed hydrolysates had less weight gain (17.4 ± 3.4 vs. 20.5 ± 3.3 g/kg/




















   
   
   
   
   
   
   
   
   
   
   























weight (–0.18 ± 0.16 vs. 0.00 ± 0.09; p = 0.009) and/or head circumference 
(–0.06 ± 0.13 vs. 0.06 ± 0.13; p = 0.049). After 2 weeks, infants receiving 
hydrolyzed formula also had higher urinary levels of essential amino acids. 
These data point to a lesser nutritional value of hydrolyzed than intact pro-
teins for infants.
In term infants, Rigo et al. [38] compared growth parameters, biochemi-
cal indices of protein metabolism and plasma amino acid concentrations in 
infants fed either human milk or 5 different hydrolyzed formulae during the 
first month of life. While growth parameters and the various protein con-
centrations determined were similar in whey hydrolysate formulae to those 
observed with human milk, the other hydrolysates led to a lesser gain in 
weight and in other growth parameters. Biochemical parameters, such as 
blood urea nitrogen, serum total protein, transferrin and plasma amino acids, 
differed between the groups fed different hydrolysates.
In a controlled study from 6 weeks to 6 months of age, term infants were 
breastfed or fed regular formula based on intact CMP, two different casein 
hydrolysates, or a whey hydrolysate [39]. Infants fed the casein hydrolysate 
formulae had significantly lower serum ferritin and significantly higher serum 
urea nitrogen values than the other groups. In all hydrolysate formula groups, 
the plasma amino acids, threonine, valine, phenylalanine, methionine, and 
tryptophan, were significantly higher than in the breastfed control group. 
Individual amino acid concentrations differed between the different hydro-
lysate groups. The authors concluded that the amounts of amino acids pro-
vided by hydrolyzed formulae is excessive compared with regular formula, 
which is reflected by the high serum urea nitrogen and plasma amino acid 
concentrations, and they suggested that a reduced and more balanced amino 
acid content of hydrolyzed formulae may be beneficial.
Conclusions and Outlook
Proper diagnostic assessment is essential for the diagnosis of food allergy. 
Elimination diets should only be introduced and maintained if one can expect 
a clear benefit. Antigen elimination with improvement in symptoms and food 
challenge with recurrence of symptoms still remains the gold standard for 
food hypersensitivity. Effective treatment with complete elimination requires 
good counseling and training, and transparent labeling of food product com-
ponents. Infants and young children need breast milk, and if not available 
or tolerated, a milk substitute with extensively hydrolyzed protein or amino 
acid-based formula should be supplied. The continued need for elimination 
diets must be reexamined over time, and repeated food challenges be con-
sidered. Further research is needed to assess the best strategies to assume 
tolerance as early as possible. With adequate treatment, a good outcome and 
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Discussion
Dr. Isolauri: I would like to make one comment on better growth with one formula 
compared to the other. In children who have early onset cow’s milk allergy there is 
frequently failure to thrive especially if they have gastrointestinal (GI) symptoms, and 
this is due to local inflammation and by putting them on elimination diets. The sooner 
the inflammation stops the better they grow. So better growth in these children is not 
simply that they grow bigger but they have faster catch-up growth and their clinical 
problems resolve sooner. Do you agree with this or do you want to clarify what you 
mean by better growth?
Dr. S. Koletzko: No, I think you have to distinguish between therapy and preven-
tion. If you look at therapy of course, many of them have failure to thrive due to GI 
involvement even if it is not obvious. You have shown that they have loss of albumin 
and mild enteropathy, many of them with atopic dermatitis. So I think treatment and 
catch-up growth are very important, but the difference is if it is given for prevention. 
I don’t say that bigger is better, I only can point out that, in the GINI study, one group 




















   
   
   
   
   
   
   
   
   
   
   























don’t want to comment on which is better or worse, but to point out there are differ-
ences and they are probably due to either intake or metabolic effects.
Dr. Haschke: You pointed out, and I fully agree with you, that only a small minor-
ity of children have a proper diagnosis established before treatment. Committees 
make recommendations for proper diagnosis but when it comes to day-to-day practi-
cal application it is not so easy to follow complex procedures and provide the neces-
sary logistics. To get an appointment for proper testing sometimes takes weeks, i.e. 2 
weeks more with suffering. Therefore, many doctors change the diet without having 
established the proper diagnosis. Diagnostic tools and procedures should be simpli-
fied. How do you feel about this?
Dr. S. Koletzko: I agree, for a pediatrician in practice or a general physician it is 
more difficult than in a hospital setting. Many children are put on elimination diets or 
therapeutic formulas which, as a first step, is correct because every child should have 
a chance to improve whatever the symptoms are. But what is of concern is that they 
are kept on the diet although their symptoms don’t even improve. They are not re-chal-
lenged to see whether improvement was by chance or had something to do with the 
elimination. We could see that in the GINI study where we were forced to do challenges. 
I think there is no excuse for not following this elimination challenge procedure, espe-
cially in children with unspecific symptoms like skin or GI symptoms. I think if you have 
angioedema it is much easier. The access for appointments may differ from country to 
country. I have no answer; I can’t solve the logistic problems of the health systems in the 
different countries. I think we all should put an effort into following this simple strategy 
in order to avoid unnecessary diets.
Dr. Haschke: If the proper diagnosis cannot be established on time, Neocate® as 
an amino acid-based solution has been promoted (‘try it, it will help you’). The com-
pany marketing Neocate is aggressively stepping in to grab the field before a proper 
diagnosis can be established.
Dr. S. Koletzko: I agree with you completely that we must try to counteract this 
aggressive marketing of products. I think trying something might be alright for a few 
days, but then you need a physician to do the proper workup, and everything else 
should not happen.
Dr. Venter: You showed that in the GINI study the children on extensively hydro-
lyzed formulas had less growth compared to the other formulas. Did you also look at 
volumes taken? Did they grow less because they actually drank less of the formula 
compared to the others?
Dr. S. Koletzko: No, the length of formula feeding was the same; it was body 
weight gain which was different. No we did not measure the volumes so we don’t know 
whether the intake was less because perhaps of poor taste or other reasons. We were 
unable to control for that in our protocol.
Dr. Kneepkens: Thank you for a very clear overview of the pros and cons of food 
elimination. You very clearly showed the negative effects as well. I think we both 
agree that it is very important for the diagnosis to be made as accurately as possible. 
Therefore I wonder why you would accept open challenges as proof of food allergy. 
There are studies from the Netherlands showing that only one third of the children 
who tested positive with open challenges were proven to really have cow’s milk allergy 
when they underwent double-blind provocation.
Dr. S. Koletzko: In infants this is for practical reasons, otherwise the availabilities 
of health facilities are even more complicated. If you do an open challenge and the 
child is tolerating then you don’t need a blind one, but if you have a reaction and if 
there is doubt, e.g. a flair up of skin or eczema, then this open challenge should be 
followed by a double-blind. But I think to ask for a double-blind as first line for all 




















   
   
   
   
   
   
   
   
   
   
   























Dr. Kneepkens: I agree with you that when an open challenge doesn’t provoke any 
reaction, a double-blind challenge is not necessary, but I think that all children with a 
positive open challenge, even if the challenge seems to be clearly positive, should be 
double-blindly challenged. Otherwise too many children will be prescribed elimination 
diets.
Dr. S. Koletzko: I think again you have to balance because double-blind challenge 
needs to be done in hospital, the other can be on an outpatient basis. I think we have 
to be aware of the problem and have to make individual decisions, but we have to be 
aware that open challenge can be false-positive. I agree with you that in older children 
we should aim for double-blind challenges.
Dr. Isolauri: One comment to this specific question. We made a study where we 
randomized infants to open and double-blind challenges and in the unselected group 
randomly assigned to one of these two groups there were no differences in the rate of 
positive reactions in infancy. I also think infancy is a critical period to introduce new 
foods. Therefore, accurate diagnosis is crucial to promote age-appropriate diets also 
in the allergic infant. So this is a very practical early treatment rather than repeated 
challenges.
Dr. S. Koletzko: No, I don’t agree. I think if an infant on a therapeutic diet who 
improves after elimination of cow’s milk formula should be challenged within a decent 
time, 2–4 weeks and not kept for months, or did I misunderstand you?
Dr. Isolauri: I said that once you have the diagnosis of cow’s milk allergy, concen-
trate on treating the child and put some age-appropriate solid foods in the diet and 
then repeat the challenge after 6 months, either openly or in a blinded manner.
Dr. S. Koletzko: I agree, and this is actually according to the algorithms which can 
be easily done in an outpatient setting in the vast majority of the infants.
Dr. Berdel: There are also hydrolyzed soy formulas on the market. Are there the 
same recommendations and the same restrictions?
Dr. S. Koletzko: It is not clear how much phytate and isoflavones are contained in 
hydrolyzed soy protein. It is a mixture of hydrolyzed collagen and soy. Based on cow’s 
milk protein the isoflavone and phytate contents are of course higher in this hydro-
lyzed formula. The restrictions also depend on the level, whether it is 20 or 80%. But it 
is not clear how much there is in there and I think it should be declared.
Dr. von Berg: After diagnosis and elimination or putting the child on a hydro-
lysate, at what time would you do the re-challenge?
Dr. S. Koletzko: It depends on the organ manifestation. If there is an acute reac-
tion and a positive challenge result, at some point specific IgE will be measured, and if 
it is positive I would wait at least 6 months or at least after the age of 1 year, and then 
I would repeat it. It is different in children who have bloody mucous diarrhea with and 
without breastfeeding or cow’s milk feeding, what we call allergic colitis. There are 
good studies showing that this is a more benign or self-limiting disease. Many of these 
children are put on a therapeutic diet but may not even have cow’s milk allergy. In 
these children we re-challenge much earlier, after 3 months or so or when they have 
supplementary feeding, and many of them tolerate cow’s milk. So it depends on the 
manifestation and whether they were IgE-positive or not.
Dr. Baerlocher: Relating to the study you showed from Utrecht where a stronger 
reaction was found following the accidental intake of allergens, I thought this was 
an old clinical allergological experience. I have seen this several times in children 
who were on a strong diet and had an accidental intake, the reaction was much 
stronger.
Dr. S. Koletzko: The difference is that these 11 children were selected from an 
outpatient clinic and had never had a reaction before. They were put on the diet with-




















   
   
   
   
   
   
   
   
   
   
   























were highly allergic children. But still the question remains, would the outcome have 
been different if they had been kept on cow’s milk protein early in life? Nobody knows 
the answer. What you said is correct. We know that following prolonged elimination, 
an acute reaction can be even more severe in accidental ingestion. The observations 
point to what we heard previously that continuous small amounts may induce toler-
ance rather than strict elimination, and I think this needs to be evaluated.
Dr. Szajewska: I have a question related to the guidelines regarding treatment 
which you published some time ago [1]. When I read them I had the impression that 
there was a lot of emphasis on the elemental diet, and as Dr. Haschke mentioned, 
there was also a lot of attention paid to this diet during the World Congress. Here as 
I listened to your lecture, I had the impression that you are not very much in favor 
of this treatment anymore. Could you comment on the place of the elemental diet 
in the treatment of cow’s milk allergy? My second question is, if it were not for the 
price, which is very high in many countries, would you have started treatment with the 
elemental diet and then gone over to an extensively hydrolyzed formula?
Dr. S. Koletzko: With respect to this publication, first of all it is clearly stated that 
in all children with mild to moderate manifestations, whatever organ, hydrolyzed for-
mula is first choice. Only in children who do not tolerate or do not improve or may 
refuse to drink, you can give a trial of amino acid. The exception is stated in the paper, 
although it is not evidence-based, it is practical in children with severe reactions, 
acute life-threatening reactions, that you should not take the risk of 10% not tolerat-
ing the hydrolyzed formula, and they should be put directly on amino acid just to be 
on the safe side. Actually that is not that much different from what I said today. I want 
to point out that several mistakes were made in this original publication. Especially 
the algorithm for formula-fed infants was wrong. We have asked to have this article 
reprinted with the correct figure.
Dr. Allen: Regarding the Australian guidelines for the use of soy in the over 
6-month-old group; in Australia we are not as keen as the European and US guidelines 
to discard the use of soy in the over 6-month age group because soy formula is not the 
sole food. There appears to be a low risk of allergy, only 10% of the children are likely 
to be allergic to soy, and we don’t really know the risk for the non-IgE-mediated group 
as we do for IgE-mediated group. About 90% of children with cow’s milk allergy toler-
ate soy, so that’s a large proportion. There is also the question of whether we are medi-
calizing a condition where in Australia the child maternal health nurses will often put 
children onto soy in the interim before they get to a doctor and the children improve. 
So my question is, in Europe are you seeing a change in referral patterns of children 
with cow’s milk allergy and an increase in referrals to specialists? In Australia we have 
a significant problem with waiting lists at our allergy clinics.
Dr. S. Koletzko: For a child on exclusive formula feeding, the reasons for not choos-
ing soy milk in the first half year are the high development or high risk of soy allergy, 
and all the other associated disadvantages. I think putting a child on soy milk while 
waiting for an appointment with a specialist is even worse because the sensitized child 
may have a gut lesion. One option could be that the general physician puts the child on 
an extensively hydrolyzed formula to await the specialist appointment. But this differs 
from country to country. Perhaps it is a health source problem, and it is very different 
in various countries even within Europe. In some countries these children are cared 
for by specialists, and in some countries they are cared for by pediatricians, unless 
they have complications.
Dr. Allen: My point is that we may not be seeing these children in the clinics if 
they have already been treated with soy because soy is not a medicalized formula, it is 
an over-the-counter formula in Australia. We think there are as many as 2–4% of chil-




















   
   
   
   
   
   
   
   
   
   
   























Dr. S. Koletzko: But then you may advise that soy formula is really not a good 
choice in the first year of life. If you make a strong point to all pediatricians regardless 
of allergy, this may help you get the referrals before they are put on soy.
Dr. Allen: We are actually suggesting that in the first 6 months soy should be 
avoided, but by 6–12 months it is alright to use soy.
Dr. Heine: Just a comment on the need for diagnostic food challenges. It is impor-
tant to distinguish between IgE-mediated and non-IgE-mediated cow’s milk allergy. In 
the IgE-mediated form, skin testing can often help us avoid food challenges. Difficulties 
often arise in the non-IgE-mediated GI forms. Challenges in these patients should be 
performed after nutritional stabilization has been achieved on an elimination diet, but 
not while the child is still in a phase of catch-up growth. This could otherwise induce 
adverse feeding behaviors. Once the nutritional and behavioral effects of GI food 
allergy have settled, gradual normalization of the diet can be attempted.
Dr. S. Koletzko: That is what we have written in the guidelines. They should be 
kept on diagnostic therapy until they have stabilized and are no longer in a catabolic 
state.
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